These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19567528)

  • 1. Acute effects of testosterone infusion on the serum luteinizing hormone profile in eumenorrheic and polycystic ovary syndrome adolescents.
    Ropelato MG; Rudaz MC; Escobar ME; Bengolea SV; Calcagno ML; Veldhuis JD; Barontini M
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3602-10. PubMed ID: 19567528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
    Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome.
    Ropelato MG; Garcia-Rudaz MC; Castro-Fernandez C; Ulloa-Aguirre A; Escobar ME; Barontini M; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4629-36. PubMed ID: 10599730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the joint synchrony of luteinizing hormone, testosterone, and androstenedione secretion in adolescents with polycystic ovarian syndrome.
    Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
    J Clin Endocrinol Metab; 2001 Jan; 86(1):72-9. PubMed ID: 11231981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome.
    García-Rudaz MC; Ropelato MG; Escobar ME; Veldhuis JD; Barontini M
    Eur J Endocrinol; 1998 Dec; 139(6):621-30. PubMed ID: 9916868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome.
    Garcia-Rudaz MC; Ropelato MG; Escobar ME; Veldhuis JD; Barontini M
    Eur J Endocrinol; 2002 Aug; 147(2):207-16. PubMed ID: 12153742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
    Hayes FJ; Taylor AE; Martin KA; Hall JE
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2343-9. PubMed ID: 9661606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
    Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparate serum free testosterone concentrations and degrees of hypothalamo-pituitary-luteinizing hormone suppression are achieved by continuous versus pulsatile intravenous androgen replacement in men: a clinical experimental model of ketoconazole-induced reversible hypoandrogenemia with controlled testosterone add-back.
    Zwart AD; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2062-9. PubMed ID: 9215273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered multihormone synchrony in obese patients with polycystic ovary syndrome.
    Roelfsema F; Kok P; Veldhuis JD; Pijl H
    Metabolism; 2011 Sep; 60(9):1227-33. PubMed ID: 21272901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase.
    Sagnella F; Apa R; Guido M; Villa P; Spadoni V; Miceli F; Lanzone A
    Fertil Steril; 2009 May; 91(5):1857-63. PubMed ID: 18538325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A; Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids.
    Eagleson CA; Bellows AB; Hu K; Gingrich MB; Marshall JC
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5158-62. PubMed ID: 14602743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
    Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal weight men.
    Aloi JA; Bergendahl M; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 1997 May; 82(5):1543-8. PubMed ID: 9141547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muting of androgen negative feedback unveils impoverished gonadotropin-releasing hormone/luteinizing hormone secretory reactivity in healthy older men.
    Veldhuis JD; Zwart A; Mulligan T; Iranmanesh A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):529-35. PubMed ID: 11158004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?
    Dunaif A
    J Clin Endocrinol Metab; 1986 Jul; 63(1):215-21. PubMed ID: 3086357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.